Physician profile

Steven Bernstein

Foot & Ankle Surgery · Fort Lee, NJ

NPI 1427221712

$46,720.84

in general payments reported to CMS, 2019-2025

35 companies · $15K in 2025

The $15K reported for 2025 was more than what 97% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$12,200.00
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$3,750.00
Travel and Lodging$2,551.90
Food and Beverage$2,299.25

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Royal Biologics, INC. $22,965.89 2019-2025
Ebi, LLC $9,171.52 2025 Biomet Orthopak Non-Invasive Bone Growth Stimulator System, Ebi Osteogen Implantable Bone Growth Stimulator, Biomet Ebi Bone Healing System
Vilex LLC $4,272.00 2020-2022
Arthrex, INC. $4,211.00 2019-2025
Highridge Medical LLC $1,297.19 2024-2025 Biomet Ebi Bone Healing System, Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System
Seapearl East, INC $1,073.38 2019-2024
Zimvie INC. $842.73 2023-2024
Bone Support INC. $377.42 2022-2024 Ceramentbone Void Filler, Cerament G
Medtronic, INC. $318.16 2025 Inceptiv
Anika Therapeutics, INC. $290.38 2024-2025 Integrity Implant, Integrity, Tactoset
Ossio INC $215.91 2023
Stryker Corporation $169.36 2019-2025 Citrefix, 7 X 23mm Citrelock Implant
Cpm Medical Consultants, LLC $154.17 2023 Fuse Ultra Foot Plating System
Horizon Therapeutics Plc $152.52 2020-2021
Treace Medical Concepts, INC. $148.06 2021-2022
Show all 35 companies
CompanyGeneral paymentsYearsTop products
Depuy Synthes Sales INC. $144.26 2023 Dynatape, Healix Knotless Peek
Ossdsign USA Incorporated $136.48 2025 Ossdsign Catalyst
Wright Medical Technology, INC. $125.39 2019
Biocomposites INC $94.23 2021-2025 Stimulan
Smith+Nephew, INC. $77.85 2021-2025 Double Pump Rf
Misonix INC $67.82 2019-2021
Ermi LLC $58.90 2019-2020
Zimmer Biomet Holdings, INC. $47.15 2019-2022
Bioventus LLC $42.65 2019-2022
Integra Lifesciences Corporation $37.85 2019-2020
Medartis INC. $32.32 2023 Aptus
Davol INC. $30.33 2022
Arteriocyte Medical Systems, INC. $26.98 2022
Curonix LLC $25.87 2025 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A
Abbvie INC. $24.85 2022
Paragon 28, INC. $24.63 2021
Kerecis Limited $19.49 2025 Kerecis Surgiclose, Kerecis Graftguide
Heron Therapeutics, INC. $15.81 2021
Merck Sharp & Dohme LLC $14.16 2019
Musculoskeletal Transplant Foundation INC. $14.13 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Steven Bernstein

$46,720.84

in general payments reported 2019-2025

Years
2019-2025
Top company
Royal Biologics, INC.
Context
The $15K reported for 2025 was more than what 97% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).

https://glasscript.com/doctor/336779/steven-bernstein

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.